APAC and MENA Prefilled Syringes Market to hit US$ 6.13 billion by 2033 | Top Companies 2025 - BD, Terumo Corporation, Sanofi S.A.

"The APAC and MENA prefilled syringes market size reached US$ 2.28 billion in 2024 and is expected to reach US$ 6.13 billion by 2033, growing at a CAGR of 12.0% during the forecast period 2025-2033." As per DataM intelligence research report

Download your exclusive sample report today: (corporate email gets priority access): https://www.datamintelligence.com/download-sample/apac-and-mena-prefilled-syringes-market?sp

APAC

Recent Launches and Investments

✅ In July 2025, Terumo Corporation launched a new line of prefilled syringes designed for biologics and vaccines in APAC markets. The syringes feature enhanced safety and reduced drug wastage. They target hospitals and clinics seeking efficient delivery systems.

✅ In March 2025, BD (Becton Dickinson) expanded its prefilled syringe manufacturing facility in Singapore to meet growing regional demand. The investment focuses on automation and production efficiency. It supports large-scale vaccine and therapeutic distribution.

Mergers and Acquisitions

✅ In August 2025, Baxter International acquired a regional prefilled syringe manufacturer in APAC. The acquisition strengthens Baxter's biologics delivery capabilities. It enhances supply chain resilience across multiple countries.

✅ In May 2025, Fujifilm partnered with a local prefilled syringe technology company to co-develop advanced injection systems. The collaboration focuses on safety, accuracy, and regulatory compliance. It targets both human and veterinary medicine applications.

MENA

Recent Launches and Investments

✅ In July 2025, Saudi Arabian-based PharmaTech launched prefilled syringes for vaccines and biologics with improved sterility and stability. The products target hospitals and immunization centers across the region. They aim to enhance patient safety and administration efficiency.

✅ In March 2025, GlaxoSmithKline expanded its prefilled syringe operations in the UAE to support vaccine distribution and specialty therapies. The facility upgrade emphasizes automation and quality control. It strengthens regional healthcare infrastructure.

Mergers and Acquisitions

✅ In August 2025, Julphar (Gulf Pharmaceutical) acquired a prefilled syringe manufacturer to expand its portfolio in biologics delivery. The acquisition enhances manufacturing capabilities. It supports market expansion across the MENA region.

✅ In May 2025, Hikma Pharmaceuticals partnered with a regional prefilled syringe technology firm to co-develop next-generation delivery devices. The collaboration focuses on safety, precision, and patient-centric design. It targets hospitals and specialty clinics.

APAC and MENA Prefilled Syringes Market: Drivers

The prefilled syringes market in APAC is witnessing robust growth as healthcare systems in the region increasingly adopt advanced drug delivery solutions for vaccines, biologics, and chronic disease management. Rising prevalence of chronic diseases, growing vaccination programs, and increasing demand for self-administration therapies are driving adoption. Technological advancements in prefilled syringe design, including safety features, auto-disable mechanisms, and high-quality glass or polymer materials, are enhancing reliability and patient compliance. Expansion of pharmaceutical manufacturing and biopharmaceutical production hubs in countries like China, India, and Japan is supporting market growth. With increasing awareness about safe, convenient, and precise drug delivery, prefilled syringes are gaining prominence across hospitals, clinics, and home care settings in APAC.

In the MENA region, the prefilled syringes market is growing steadily as governments and healthcare providers focus on improving immunization coverage, hospital infrastructure, and biologics administration. Rising prevalence of lifestyle-related chronic diseases and growing demand for safe, ready-to-use injection devices are driving adoption. Technological improvements, including pre-sterilized syringes and advanced polymer materials, are enhancing product safety and usability. Investments in healthcare infrastructure, pharmaceutical manufacturing, and regulatory compliance are supporting market expansion. As healthcare modernization continues and focus on patient-centric solutions increases, the prefilled syringes market in MENA is poised for sustained growth and widespread adoption.

Get Customization in the report as per your requirements: https://www.datamintelligence.com/customize/apac-and-mena-prefilled-syringes-market?sp

APAC and MENA Prefilled Syringes Market: Major Players

BD, Terumo Corporation, Sanofi S.A., Hikma Pharmaceuticals PLC, Cardinal Health, Nipro Corporation, and B. Braun SE among others.

Segment Covered in the APAC and MENA Prefilled Syringes Market:

➥ By Product Type: Needle-Free Prefilled Syringes, Needled Prefilled Syringes
➥ By Material: Glass Prefilled Syringes, Plastic Prefilled Syringes
➥ By Drug Type: Heparins, Biosimilars, Biologics, Others
➥ By Length: 1 Inch, 1.5 Inch, 0.5 Inch, 5/8 Inch, Others
➥ By Gauge: 29 Gauge, 28 Gauge, 27 Gauge, 22 Gauge, 21 Gauge, 20 Gauge
➥ By Design: Single-Chambered PFS, Dual-Chambered PFS
➥ By Application: Diabetes, Rheumatoid Arthritis, Ophthalmology, Anaphylaxis, Others

Research Process:

Both primary and secondary data sources have been used in the 55 Market research report. During the research process, a wide range of industry-affecting factors are examined, including governmental regulations, market conditions, competitive levels, historical data, market situation, technological advancements, upcoming developments, in related businesses, as well as market volatility, prospects, potential barriers, and challenges.

Most Frequently Asked Questions in the APAC and MENA Prefilled Syringes Market Research Industry:

➠ Who leads the APAC and MENA Prefilled Syringes industry and what's their competitive positioning regarding capacity, performance, and profitability?
➠ What growth opportunities and market challenges do APAC and MENA Prefilled Syringes market vendors face?
➠ Which segments show the highest growth potential and market share distribution?
➠ What factors are driving or limiting APAC and MENA Prefilled Syringes market growth?
➠ What are the dominant sales and distribution strategies in the APAC and MENA Prefilled Syringes industry?

Buy Now & Unlock 360° Market Intelligence: https://www.datamintelligence.com/buy-now-page?report=apac-and-mena-prefilled-syringes-market

Regional Analysis:

⇥ North America (U.S., Canada, Mexico)
⇥ Europe (U.K., Italy, Germany, Russia, France, Spain, The Netherlands and Rest of Europe)
⇥ Asia-Pacific (India, Japan, China, South Korea, Australia, Indonesia Rest of Asia Pacific)
⇥ South America (Colombia, Brazil, Argentina, Rest of South America)
⇥ Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of Middle East & Africa)

Request for 2 Days FREE Trial Access:
https://www.datamintelligence.com/reports-subscription?sp

✅ Competitive Landscape
✅ Technology Roadmap Analysis
✅ Sustainability Impact Analysis
✅ KOL / Stakeholder Insights
✅ Consumer Behavior & Demand Analysis
✅ Import-Export Data Monitoring
✅ Live Market & Pricing Trends

Have a look at our Subscription Dashboard:
https://www.youtube.com/watch?v=x5oEiqEqTWg

Contact Us -
Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

About Us -
DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.
Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.